Sidonie Roswitha Golombowski-Daffner

Sidonie Roswitha Golombowski-Daffner

Director/Board Member at PAUL HARTMANN AG
Health Technology
Process Industries
Electronic Technology

Profile

Sidonie Roswitha Golombowski-Daffner is Co-Managing Director at Novartis Pharma Arzneimittel GmbH.
She is a Member of the Supervisory Board at PAUL HARTMANN AG since 2023 and at Gerresheimer AG since 2024.
Former roles include Chairman-Management Board at CIBA Vision GmbH (Germany), Chairman & President at Advanced Accelerator Applications SA, and President-Advanced Accelerator Applications at Novartis AG from 2019 to 2023.

Sidonie Roswitha Golombowski-Daffner active positions

CompaniesPositionStart
PAUL HARTMANN AG Director/Board Member 28/04/2023
GERRESHEIMER AG Director/Board Member 05/06/2024
Chief Executive Officer -

Former positions of Sidonie Roswitha Golombowski-Daffner

CompaniesPositionEnd
NOVARTIS AG Corporate Officer/Principal 31/12/2023
ADVANCED ACCELERATOR APPLICATION SA(ADR) Chairman -
Chief Executive Officer -
See the detail of Sidonie Roswitha Golombowski-Daffner's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Process Industries

Health Technology

Electronic Technology

Distribution Services

  1. Stock Market
  2. Insiders
  3. Sidonie Roswitha Golombowski-Daffner